Pilot Study to Assess Feasibility and Safety of Bone Marrow as Alternative Site in Islet Transplant Patients

NCT01345227 NA COMPLETED

The goal of this study is to evaluate safety and feasibility of bone marrow (BM) as site for islet transplantation (Tx) in humans. The investigators hypothesis is that BM represents a better site than liver thanks to its potential capacity to favor islet engraftment in face of a more easiness of access and bioptic follow up.

Details

Lead sponsor	Ospedale San Raffaele
Phase	NA
Status	COMPLETED
Enrolment	8
Start date	2009-08
Completion	2011-10

Conditions

• Type 1 Diabetes
• Postpancreatectomy Hyperglycemia

Interventions

• Intra bone marrow islet infusion

Primary outcomes

• Adverse events related to the procedure of intra bone marrow islet infusion — up to 3 years

Countries

Italy